NewsCuraleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC...

Curaleaf Enters Europe’s Largest Medical Cannabis Market Following EMMAC Move

-

FOLLOWING its recent acquisition of UK-firm EMMAC Life Sciences leading US player Curaleaf has wasted no time in expanding into Europe’s biggest medical cannabis market.

Curaleaf International (formerly EMMAC), through its wholly owned subsidiary Adven has launched its own range of medical cannabis products into Germany.  

It says the initial product launch of a high-THC oil product will be extended over the next few months to incorporate a number of different strengths and THC/CBD formulations in both oils and flower. 

Adven Managing Director Julian Vaterrodt said: “German patients and practitioners are increasingly demanding high-quality, consistent and reliable European natural alternatives to help manage a wide range of complaints.  

“Adven is committed to providing a differentiated product and service for the German market.”

Antonio Costanzo, CEO of Curaleaf International, added: “Curaleaf International’s European supply chain, from cultivation to product research and development and EU-GMP manufacturing processes across Europe, means we are able to guarantee a consistency of product and price to clinicians and patients in need of the highest quality medical cannabis.”

In its recent sixth European Cannabis Report Prohibition Partners estimates Germany had 128,000 active patients at the end of 2020. 

Its medical cannabis products are currently sourced from a wide range of countries including Canada, Netherlands, Uruguay, Portugal, Israel, Spain and Australia.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to outlaw the sale of CBD flowers despite recent decisions to...

UK CBD Brand OTO Signs Deal With Synthetic CBD Brand Pureform Global

LONDON-based wellness and CBD brand, OTO, have signed a partnership deal with Pureform Global. This groundbreaking partnership will enable...

Significant Year-On-Year Rise In German Medical Cannabis Flower Imports

DESPITE a decline in cannabis flower imports for the first quarter of 2021 the German medical cannabis market continues...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical cannabis flower for the first time in what could be...

UK Cannabis Business Eco Equity Announces 100% Equity Acquisition By US Firm Virtual Medical International

ECO Equity Limited a UK company with cultivation assets in Africa, will combine its operations with Virtual Medical International...

New Amendments Could Delay Passing Of Greek Medical Cannabis Bill Until Next Year

GREEK businesses are preparing for amendments to the Mediterranean country’s cannabis laws allowing the cultivation, sale and export of...

Must read

New French Hemp Rules Under-fire Over Proposals To Outlaw CBD Flowers

THE French government is pressing ahead with moves to...

Low-Cost Medical Cannabis Flowers To Be Exported From Colombia For The First Time

COLOMBIA is set to permit the export of medical...

You might also likeRELATED
Recommended to you